We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia’s TGA Re-Tests COVID-19 Antibody Tests
As part of a postmarket review, Australia’s Therapeutic Goods Administration (TGA) is reviewing all approved serology-based COVID-19 point-of-care tests to verify their ability to detect SARS-COV-2 antibodies.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor